MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Затворен

5.01 0.2

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.01

Максимум

5.01

Ключови измерители
By Trading Economics
Приходи	1.3M -3M
Продажби	100K 100K
Марж на печалбата	-2,954
Служители	21

Дивиденти
By Dow Jones
Следващи печалби	7.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	531K 40M
Предишно отваряне	4.81
Предишно затваряне	5.01

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.04.2026 г., 17:11 ч. UTC

Значими двигатели на пазара

Значими събития в новините

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2.04.2026 г., 17:10 ч. UTC

Значими събития в новините

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3.04.2026 г., 00:00 ч. UTC

Значими събития в новините

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2.04.2026 г., 23:47 ч. UTC

Пазарно говорене

Значими събития в новините

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2.04.2026 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2.04.2026 г., 21:01 ч. UTC

Значими събития в новините

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2.04.2026 г., 20:59 ч. UTC

Придобивния, сливания и поглъщания

Starbucks and Boyu Capital Finalize China JV

2.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

2.04.2026 г., 20:41 ч. UTC

Печалби

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2.04.2026 г., 20:32 ч. UTC

Пазарно говорене

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2.04.2026 г., 20:30 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 20:09 ч. UTC

Пазарно говорене

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2.04.2026 г., 20:01 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 19:46 ч. UTC

Пазарно говорене

Is Oil the New GameStop? -- Market Talk

2.04.2026 г., 19:35 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2.04.2026 г., 19:29 ч. UTC

Придобивния, сливания и поглъщания

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2.04.2026 г., 19:24 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2.04.2026 г., 19:20 ч. UTC

Пазарно говорене

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2.04.2026 г., 19:01 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2.04.2026 г., 19:00 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific: Agreement Reached With American Train Dispatchers Association

2.04.2026 г., 18:24 ч. UTC

Придобивния, сливания и поглъщания

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2.04.2026 г., 17:44 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2.04.2026 г., 17:32 ч. UTC

Значими събития в новините

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2.04.2026 г., 17:26 ч. UTC

Печалби

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2.04.2026 г., 17:17 ч. UTC

Пазарно говорене

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2.04.2026 г., 17:09 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Печалба преди облагане с данъци

Продажби

Оперативна печалба

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.